Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

FDA Grants Fast Track Designation to Naurex's Rapid-Acting Novel Antidepressant GLYX-13
EVANSTON, IL - MARCH 3, 2014 - Naurex Inc. today announced that the U.S. Food and Drug Administration (FDA) has... Read more
Profound Medical Inc. Announces U.S. Initiation of TULSA Clinical Trial for Treatment of Localized Prostate Cancer at Be
Toronto, Ontario (PRWEB) February 20, 2014 - Today, Profound Medical Inc. announced the initiation of the TULSA (Trans Urethral Ultrasound... Read more